SEI Investments
XGN icon

SEI Investments’s Exagen XGN Stock Holding History

SEI Investments’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$507K Sell
109,005
-135,235
-55% -$509K ﹤0.01% 2631
2026
Q1 		$733K Buy
244,240
+126,235
+107% +$488K ﹤0.01% 2505
2025
Q4 		$717K Buy
+118,005
New +$1.07M ﹤0.01% 2332

Other funds holding XGN

WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $227M AUM 64.76% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

SEI Investments's XGN Position: Q2 2026 in Review

SEI Investments reduced its Exagen (XGN) stake by 55% in Q2 2026, selling an estimated $509K and leaving 109,005 shares worth $507K. The position accounts for ﹤0.01% of the portfolio, ranked #2631.

SEI Investments first reported a position in XGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $733K in Q1 2026. 57 funds tracked by Wall St. Rank hold XGN as of Q2 2026.

  • SEI Investments held 109,005 shares of Exagen worth $507K as of Q2 2026.
  • SEI Investments sold 135,235 Exagen shares in Q2 2026, an estimated $509K.
  • Exagen made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2631 holding.
  • SEI Investments first reported a position in Exagen in Q4 2025 and has held it in 3 quarters since.
  • SEI Investments's Exagen position peaked at $733K in Q1 2026.
  • 57 funds tracked by Wall St. Rank held Exagen as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.